Patient-Centered CarePCPCNCT03182283
Person-Centered Psychosis Care: An Educational Intervention
A study testing Person-centered psychosis care in people with Patient-Centered Care and Psychiatry, run by Göteborg University at 1 site in Sweden.
Trial summary
Schizophrenia is a major mental illness that presents in young adulthood and affects ~1% of the population. Impact on affected persons life is often major and life expectancy is reduced by ~20 years. Better and more effective care models are needed to increase health in these persons. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Patient-Centered Care, Psychiatry, Inpatient
- What is being tested?
- Person-centered psychosis care
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteSweden
- Study dates
- 25 Apr 2014to 1 Aug 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosis of psychotic illness in accordance with ICD-10
- Medically ready for discharge as deemed by ward psychiatrist
Who cannot join
- Severe cognitive disability
- Lack of basic Swedish language skills
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Person-Centered Psychosis Care: An Educational Intervention for Inpatient Staff
Schizophrenia is a major mental illness that presents in young adulthood and affects ~1% of the population. Impact on affected persons life is often major and life expectancy is reduced by ~20 years. Better and more effective care models are needed to increase health in these persons. Person-centered care have been suggested to be one way to increase efficiency in care delivery for patients with chronical and complex conditions. The impact of person-centered care on a inpatient psychosis care setting is now being tested.
The purpose of this study is to test whether inpatient Person-centered psychosis care (PCPC) can
Read more
- increase patient empowerment
- improve patient satisfaction
- reduce the frequency of involuntary treatments
- reduce the duration of inpatient care and
- reduce overall ward burden
A further purpose is to qualitatively explore which components in this complex intervention are experienced as facilitators or barriers to the achievement of good care, from both patient, next-of-kin and staff perspectives.
Quantitative data is collected through questionnaires from patients (measuring empowerment, care satisfaction and perceived health) before and after an educational intervention for staff, along with ward level measures such as care burden, number of involuntary treatments and length of stay on ward.
Qualitative interview is used to study experiences of patients, next-of-kin and staff.
Read the detailed description
Background
Schizophrenia is a major mental illness that presents in young adulthood. It affects approximately 1% of the population and is a major cause of Disability-adjusted Life Years worldwide. Besides impacting on the ability to independently carry out daily activities, work/studies and interactions with family and community, the illness has a profound effect on physical health. Diabetes and cardiovascular diseases are common complications and life expectancy is reduced by as much as two decades. The long term nature of this complex illness highlights the need for more effective, holistic care models. Increased patient involvement is central, as it has been shown that patients' views of appropriate interventions often differ from those of formal care providers.
Person-centered care (PCC) is recognized by the WHO as a valuable approach to the care of chronic conditions. A basic assumption of person-centered care (PCC) is that healthcare must recognize the patient as a person, with own knowledge, capacity and preferences along with needs and problems. The PCC way to deal with illness and disease is to form a partnership with the person and together form a plan of action to increase health (i.e. not only focus on symptoms or signs of diagnosed disease) taking into account the person's context and priorities. Previous studies show that persons with serious mental illness can and want to participate in their own care and participation might increase adherence. Improved social function and consumer satisfaction were demonstrated when a person-centered care approach, Integrated Care (IC) was tested in a psychosis outpatient-based randomized controlled trial.
To the best of the authors knowledge, PCC has yet to be tested in an inpatient setting for persons with severe mental illness. Favorable results have been demonstrated with regard to both ward level and patient level outcomes from inpatient settings within somatic care. Person-centered care in geriatric settings, which might share some common issues with hospital care for persons with schizophrenia (decreased cognitive function, lack of insight, compromised autonomy), have shown positive outcomes for QoL and agitation in patients and job satisfaction for staff. Reviews show mixed results though. Thus, we wanted to evaluate an intervention for inpatient psychiatric care for persons with schizophrenia and similar psychoses. To this end, we developed Person-centered Psychosis Care (PCPC), a staff educational intervention involving components of PCC as well as IC. Person Centered Psychosis Care was defined as having four key elements; dialogue, building partnership, formulation and documentation of a health plan, and early involvement of the patient's outpatient facility. The latter means that the patient's outpatient-based social resource group can come into play already during the inpatient stay.
Purpose
The purpose of this study is to test whether inpatient PCPC can
- increase patient empowerment
- improve patient satisfaction
- reduce the frequency of involuntary treatments
- reduce the duration of inpatient care and
- reduce overall ward burden A further purpose is to qualitatively explore which components in this complex intervention are experienced as facilitators or barriers to the achievement of good care, from both patient, next-of-kin and staff perspectives. Methods The study employs a simple "before and after" design. Quantitative data (patient-level, ward-level) are collected pre- and post intervention on all four wards. Qualitative data are provided through interviews with patients as well as focus groups with staff. Data collection: Patient-level data All patients on any of the four wards who fulfill study criteria during pre- and post-intervention periods will be asked to participate in the study. Anticipated number of participants: 50 pre intervention, 50 post intervention.Those who accept will complete questionnaires at the clinic together with the interviewer. The following outcomes will be measured:
- Empowerment will be measured with The Empowerment Scale. This scale is validated and used internationally in studies involving persons with severe mental ill-health. There are 28 questions; responses are given on a scale of 1 (agree totally) to 4 (disagree totally).
- Patient satisfaction measured with the UKU-ConSat Rating Scale consists of 11 items on different aspects of the care provided where response is given on a scale 1 (Very bad/negative/little) to 7 (very good/positive/much). The scale also includes two VAS-like scales where an answer is marked on a 100 mm line to a question on overall life experience (0=worst imaginable, 100=best imaginable). Confounders including illness burden, functional ability, and overall health will be quantified for each patient at discharge. Positive and negative symptom burden will be rated with the Remission subscale of PANSS, consisting of 8 items reflecting core symptoms of schizophrenia and functional ability will be determined using the GAF scale and overall health with the EQ-5D. Ratings will be carried out by two nurses and one psychologist. After the completion of the scales, all participants are asked the following open-ended questions: 1a) What are the most important things that have improved for you during your stay at the hospital? 1b) What was the reason that you got better? 2a) What do you wish could improve for you in the future, after your hospital stay? 2b) How could the health care sector help you to achieve this? At the end of the interview, participants are asked for permission for researchers to contact them after discharge for invitation to a qualitative interview study. A purposive selection of stabilized patients who accepted follow-up contact will be asked if they would like to participate in an interview with a study nurse or psychologist. The interview will focus on experiences of care during the inpatient stay and patient-relevant endpoints will be explored. The sampling will aim at a heterogeneous group with regard to gender, age, ethnicity, level of psychosocial function, involuntary vs voluntary care. Data collection: Next-of-kin A purposive sample of family members or other persons close to the patient will be asked if they would like to participate in focus groups/an interview. The selection of family members' for focus group interview will strive to include next-of-kin of patients with varied backgrounds with regard to age, gender, ethnic background, education level, living situation (do they live together with the patient or not?) etc. The main focus for this focus group will be the identification of positive and negative experiences in the care, discrimination, facilitators and barriers for good care Data collection: Staff experiences A purposive sample of staff were invited to participate in focus group to collect experiences of the educational intervention and implementation. Facilitators and barriers to implementation of PCPC will be in focus. Staff were recruited through invitation via e-mail and posters on their wards. In a second step section leaders at the wards asked persons who would be on duty on the days of interview to participate. All focus groups are led by an experienced clinician with research experience of qualitative studies. All interviews will be recorded and transcribed verbatim. Data collection: Ward level data Mean number of inpatient days, mean number of inpatient days with compulsory care and mean number of involuntary treatment interventions (involuntary injections, medical restraint) for pre- and post intervention periods will be derived from the clinic's administrative database. Overall care burden is measured at each ward with an instrument developed by the Psychosis Clinic for quality monitoring. The instrument includes objective items (number of admissions and discharges, number of involuntary treatments during the shift etc), followed by a subjective item on the overall level of burden perceived during the shift. The form is filled out by one staff member on each ward once a day according to clinical routine. Data analysis: Quantitative data The main study question is whether the intervention is associated with a change in the degree of empowerment experienced by persons who receive hospital care due to psychosis. The secondary outcome measure is patient satisfaction at discharge. Quantitative ratings before and after the care intervention will be compared with standard statistical methods. Similarly, for the ward level analyses, wardwide outcomes will be compared in wards before and after the implementation of the intervention: mean number of inpatient days, mean number of inpatient days with compulsory care, mean number of involuntary treatment interventions and overall ward burden. Distribution of the variables to be studied will determine whether parametric or non-parametric analyses are employed. Data analysis: Qualitative data Free text responses to the open-ended questions at the end of the quantitative interview (see patient level data above) as well as data from individual patient interviews and focus group interviews with staff and next-of-kin will be analyzed using content analysis and thematic analysis. Ethics All participants (patients, next-of kin and staff) are given written and oral information about the study, the voluntary participation, possibility to withdraw from participation without having to give explanation. All will sign consent form before participating in any study related task, a copy of signed consent is given participants. The study was approved by the Regional Ethics Board in Gothenburg, Dnr. 773-13. Time plan Data collection for the pre-intervention phase is completed (December 2014); the educational intervention is completed (May 2015) and the implementation period will end April 30, 2017. Focus group interviews with staff regarding the educational package are now underway (2017). Audit to determine the level of PCPC implementation is currently underway (April 2017), which will determine whether post-intervention data collection could start. Complete data set should be available fall 2017. Comment on project so far This is a complex intervention involving action research and the study is registered first after the completion of the educational intervention and on-ward implementation of PCPC. The implementation process has been dynamic and varied at the four different wards involved in the project. The duration of the implementation period was considerably longer than anticipated. This is in part related to high staff turnover, serious lack of psychiatrically trained RNs, as well as other barriers to implementation. Barriers have slowly been overcome by changes in routines instigated from within the care staff (as opposed to being imposed on staff from "above"). While the long implementation process can be seen as a limitation, it's interactive nature can at the same time be construed as a strength, as change from within can be expected to increase sustainable change. A quantitative study was planned with questionnaires investigating consumer satisfaction and care giver burden in next-of-kin but baseline collection resulted in too few participants to continue that subproject.
- Conditions
- Patient-Centered Care, Psychiatry, Inpatient, Psychosis
- Being tested
- Person-centered psychosis care
- Keywords
- Person-centered care, Psychosis care, Integrated care
- Medical subject headings
- Psychotic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Person-centered psychosis careBehavioural
Person-centered care educational intervention for staff with following implementation of person-centered care in the clinic
| Study group | Role | What they receive |
|---|---|---|
| Pre-intervention | No intervention | All patients at the psychosis wards receive care as usual before staff goes through educational intervention. |
| Post-intervention | Other | After staff attended educational intervention and implemented Person-centered psychosis care in the wards all patients admitted will receive person-centered care. Receives: Behavioral: Person-centered psychosis care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in patient empowerment (between before and after cohorts)
Patient reported empowerment measured by The Empowerment Scale (Rogers et al 2010).
Measured: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Secondary outcomes (4)
Change in consumer satisfaction (between before and after cohorts)
Patients satisfaction with different aspects of care measured by UKU-ConSat Rating Scale (Ahlfors et al 2000).
Measured: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Change in staff care burden (before and after intervention and implementation)
Overall care burden as reported by staff daily (objective and subjective items) in an internal instrument used by the Psychosis Clinic for quality monitoring.
Measured: Baseline, 2 years
Change in inpatient days with/out involuntary care (between before and after cohorts)
Mean number of inpatient days, mean number of inpatient days with compulsory care.
Measured: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Change in involuntary treatment (between before and after cohorts)
Mean number of involuntary treatment interventions (involuntary injections, medical restraint)
Measured: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jun 2017
- Study start25 Apr 2014
- Primary completion1 Aug 2018
- Study completion1 Aug 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (28)Papers the sponsor has linked to this study.
- Other trials for Patient-Centered CareStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Model description
- Non-randomized before and after design.
- Masking
- None (open label)
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Göteborg University
- Sponsor type
- University, hospital or other
- Collaborators
- Sahlgrenska University Hospital, Swedish Council for Working Life and Social Research
- Responsible party
- Sponsor
- Investigators
- Margda Waern, Professor, Principal investigator, Göteborg University & Sahlgrenska University HospitalAnneli Goulding, Phd, Study director, Sahlgrenska University Hospital & Göteborg University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03182283
- Sponsor's protocol ID
- PCPC
- Acronym
- PCPC
- Status last verified
- Nov 2018
- First submitted
- 17 May 2017
- Last updated
- 8 Nov 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Rossler W, Salize HJ, van Os J, Riecher-Rossler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005 Aug;15(4):399-409. doi: 10.1016/j.euroneuro.2005.04.009.
PubMed 15925493von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E, Jones P. Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl. 2009;(438):15-21. doi: 10.1111/j.1600-0447.2008.01309.x.
PubMed 19132962Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009 Aug 22;374(9690):620-7. doi: 10.1016/S0140-6736(09)60742-X.
PubMed 19595447Lasalvia A, Boggian I, Bonetto C, Saggioro V, Piccione G, Zanoni C, Cristofalo D, Lamonaca D. Multiple perspectives on mental health outcome: needs for care and service satisfaction assessed by staff, patients and family members. Soc Psychiatry Psychiatr Epidemiol. 2012 Jul;47(7):1035-45. doi: 10.1007/s00127-011-0418-0. Epub 2011 Aug 18.
PubMed 21850522Hamann J, Langer B, Winkler V, Busch R, Cohen R, Leucht S, Kissling W. Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand. 2006 Oct;114(4):265-73. doi: 10.1111/j.1600-0447.2006.00798.x.
PubMed 16968364Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Do patients with schizophrenia wish to be involved in decisions about their medical treatment? Am J Psychiatry. 2005 Dec;162(12):2382-4. doi: 10.1176/appi.ajp.162.12.2382.
PubMed 16330606Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77(4):219-26. doi: 10.1159/000126073. Epub 2008 Apr 16.
PubMed 18418028Malm U, Ivarsson B, Allebeck P, Falloon IR. Integrated care in schizophrenia: a 2-year randomized controlled study of two community-based treatment programs. Acta Psychiatr Scand. 2003 Jun;107(6):415-23. doi: 10.1034/j.1600-0447.2003.00085.x.
PubMed 12752017Malm UI, Ivarsson BA, Allebeck P. Durability of the efficacy of integrated care in schizophrenia: a five-year randomized controlled study. Psychiatr Serv. 2014 Aug 1;65(8):1054-7. doi: 10.1176/appi.ps.201300164.
PubMed 24932858Ekman I, Wolf A, Olsson LE, Taft C, Dudas K, Schaufelberger M, Swedberg K. Effects of person-centred care in patients with chronic heart failure: the PCC-HF study. Eur Heart J. 2012 May;33(9):1112-9. doi: 10.1093/eurheartj/ehr306. Epub 2011 Sep 15.
PubMed 21926072Olsson LE, Karlsson J, Ekman I. Effects of nursing interventions within an integrated care pathway for patients with hip fracture. J Adv Nurs. 2007 Apr;58(2):116-25. doi: 10.1111/j.1365-2648.2007.04209.x.
PubMed 17445014Chenoweth L, Forbes I, Fleming R, King MT, Stein-Parbury J, Luscombe G, Kenny P, Jeon YH, Haas M, Brodaty H. PerCEN: a cluster randomized controlled trial of person-centered residential care and environment for people with dementia. Int Psychogeriatr. 2014 Jul;26(7):1147-60. doi: 10.1017/S1041610214000398. Epub 2014 Mar 26.
PubMed 24666667Brownie S, Nancarrow S. Effects of person-centered care on residents and staff in aged-care facilities: a systematic review. Clin Interv Aging. 2013;8:1-10. doi: 10.2147/CIA.S38589. Epub 2013 Jan 3.
PubMed 23319855Rogers ES, Ralph RO, Salzer MS. Validating the empowerment scale with a multisite sample of consumers of mental health services. Psychiatr Serv. 2010 Sep;61(9):933-6. doi: 10.1176/ps.2010.61.9.933.
PubMed 20810594Ahlfors UG, Lewander T, Lindstrom E, Malt UF, Lublin H, Malm U. Assessment of patient satisfaction with psychiatric care. Development and clinical evaluation of a brief consumer satisfaction rating scale (UKU-ConSat). Nord J Psychiatry. 2001;55 Suppl 44:71-90. doi: 10.1080/080394801317084437.
PubMed 11860667
Study at a glance
From the registry record, last updated by the sponsor on 8 Nov 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Person-Centered Psychosis Care: An Educational Intervention for Inpatient Staff
- ClinicalTrials.gov ID
- NCT03182283
- Acronym / sponsor ID
- PCPC / PCPC
- Conditions
- Patient-Centered Care, Psychiatry, Inpatient, Psychosis
- Keywords
- Person-centered care, Psychosis care, Integrated care
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Göteborg UniversityUniversity, hospital or other
- Collaborators
- Sahlgrenska University Hospital, Swedish Council for Working Life and Social Research
- Study start
- 25 Apr 2014 (actual)
- Primary completion
- 1 Aug 2018 (actual)
- Study completion
- 1 Aug 2018 (actual)
- First posted
- 9 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Schizophrenia is a major mental illness that presents in young adulthood and affects ~1% of the population. Impact on affected persons life is often major and life expectancy is reduced by ~20 years. Better and more effective care models are needed to increase health in these persons. Person-centered care have been suggested to be one way to increase efficiency in care delivery for patients with chronical and complex conditions. The impact of person-centered care on a inpatient psychosis care setting is now being tested.
The purpose of this study is to test whether inpatient Person-centered psychosis care (PCPC) can
- increase patient empowerment
- improve patient satisfaction
- reduce the frequency of involuntary treatments
- reduce the duration of inpatient care and
- reduce overall ward burden
A further purpose is to qualitatively explore which components in this complex intervention are experienced as facilitators or barriers to the achievement of good care, from both patient, next-of-kin and staff perspectives.
Quantitative data is collected through questionnaires from patients (measuring empowerment, care satisfaction and perceived health) before and after an educational intervention for staff, along with ward level measures such as care burden, number of involuntary treatments and length of stay on ward.
Qualitative interview is used to study experiences of patients, next-of-kin and staff.
Detailed description
Background
Schizophrenia is a major mental illness that presents in young adulthood. It affects approximately 1% of the population and is a major cause of Disability-adjusted Life Years worldwide. Besides impacting on the ability to independently carry out daily activities, work/studies and interactions with family and community, the illness has a profound effect on physical health. Diabetes and cardiovascular diseases are common complications and life expectancy is reduced by as much as two decades. The long term nature of this complex illness highlights the need for more effective, holistic care models. Increased patient involvement is central, as it has been shown that patients' views of appropriate interventions often differ from those of formal care providers.
Person-centered care (PCC) is recognized by the WHO as a valuable approach to the care of chronic conditions. A basic assumption of person-centered care (PCC) is that healthcare must recognize the patient as a person, with own knowledge, capacity and preferences along with needs and problems. The PCC way to deal with illness and disease is to form a partnership with the person and together form a plan of action to increase health (i.e. not only focus on symptoms or signs of diagnosed disease) taking into account the person's context and priorities. Previous studies show that persons with serious mental illness can and want to participate in their own care and participation might increase adherence. Improved social function and consumer satisfaction were demonstrated when a person-centered care approach, Integrated Care (IC) was tested in a psychosis outpatient-based randomized controlled trial.
To the best of the authors knowledge, PCC has yet to be tested in an inpatient setting for persons with severe mental illness. Favorable results have been demonstrated with regard to both ward level and patient level outcomes from inpatient settings within somatic care. Person-centered care in geriatric settings, which might share some common issues with hospital care for persons with schizophrenia (decreased cognitive function, lack of insight, compromised autonomy), have shown positive outcomes for QoL and agitation in patients and job satisfaction for staff. Reviews show mixed results though. Thus, we wanted to evaluate an intervention for inpatient psychiatric care for persons with schizophrenia and similar psychoses. To this end, we developed Person-centered Psychosis Care (PCPC), a staff educational intervention involving components of PCC as well as IC. Person Centered Psychosis Care was defined as having four key elements; dialogue, building partnership, formulation and documentation of a health plan, and early involvement of the patient's outpatient facility. The latter means that the patient's outpatient-based social resource group can come into play already during the inpatient stay.
Purpose
The purpose of this study is to test whether inpatient PCPC can
- increase patient empowerment
- improve patient satisfaction
- reduce the frequency of involuntary treatments
- reduce the duration of inpatient care and
- reduce overall ward burden A further purpose is to qualitatively explore which components in this complex intervention are experienced as facilitators or barriers to the achievement of good care, from both patient, next-of-kin and staff perspectives. Methods The study employs a simple "before and after" design. Quantitative data (patient-level, ward-level) are collected pre- and post intervention on all four wards. Qualitative data are provided through interviews with patients as well as focus groups with staff. Data collection: Patient-level data All patients on any of the four wards who fulfill study criteria during pre- and post-intervention periods will be asked to participate in the study. Anticipated number of participants: 50 pre intervention, 50 post intervention.Those who accept will complete questionnaires at the clinic together with the interviewer. The following outcomes will be measured:
- Empowerment will be measured with The Empowerment Scale. This scale is validated and used internationally in studies involving persons with severe mental ill-health. There are 28 questions; responses are given on a scale of 1 (agree totally) to 4 (disagree totally).
- Patient satisfaction measured with the UKU-ConSat Rating Scale consists of 11 items on different aspects of the care provided where response is given on a scale 1 (Very bad/negative/little) to 7 (very good/positive/much). The scale also includes two VAS-like scales where an answer is marked on a 100 mm line to a question on overall life experience (0=worst imaginable, 100=best imaginable). Confounders including illness burden, functional ability, and overall health will be quantified for each patient at discharge. Positive and negative symptom burden will be rated with the Remission subscale of PANSS, consisting of 8 items reflecting core symptoms of schizophrenia and functional ability will be determined using the GAF scale and overall health with the EQ-5D. Ratings will be carried out by two nurses and one psychologist. After the completion of the scales, all participants are asked the following open-ended questions: 1a) What are the most important things that have improved for you during your stay at the hospital? 1b) What was the reason that you got better? 2a) What do you wish could improve for you in the future, after your hospital stay? 2b) How could the health care sector help you to achieve this? At the end of the interview, participants are asked for permission for researchers to contact them after discharge for invitation to a qualitative interview study. A purposive selection of stabilized patients who accepted follow-up contact will be asked if they would like to participate in an interview with a study nurse or psychologist. The interview will focus on experiences of care during the inpatient stay and patient-relevant endpoints will be explored. The sampling will aim at a heterogeneous group with regard to gender, age, ethnicity, level of psychosocial function, involuntary vs voluntary care. Data collection: Next-of-kin A purposive sample of family members or other persons close to the patient will be asked if they would like to participate in focus groups/an interview. The selection of family members' for focus group interview will strive to include next-of-kin of patients with varied backgrounds with regard to age, gender, ethnic background, education level, living situation (do they live together with the patient or not?) etc. The main focus for this focus group will be the identification of positive and negative experiences in the care, discrimination, facilitators and barriers for good care Data collection: Staff experiences A purposive sample of staff were invited to participate in focus group to collect experiences of the educational intervention and implementation. Facilitators and barriers to implementation of PCPC will be in focus. Staff were recruited through invitation via e-mail and posters on their wards. In a second step section leaders at the wards asked persons who would be on duty on the days of interview to participate. All focus groups are led by an experienced clinician with research experience of qualitative studies. All interviews will be recorded and transcribed verbatim. Data collection: Ward level data Mean number of inpatient days, mean number of inpatient days with compulsory care and mean number of involuntary treatment interventions (involuntary injections, medical restraint) for pre- and post intervention periods will be derived from the clinic's administrative database. Overall care burden is measured at each ward with an instrument developed by the Psychosis Clinic for quality monitoring. The instrument includes objective items (number of admissions and discharges, number of involuntary treatments during the shift etc), followed by a subjective item on the overall level of burden perceived during the shift. The form is filled out by one staff member on each ward once a day according to clinical routine. Data analysis: Quantitative data The main study question is whether the intervention is associated with a change in the degree of empowerment experienced by persons who receive hospital care due to psychosis. The secondary outcome measure is patient satisfaction at discharge. Quantitative ratings before and after the care intervention will be compared with standard statistical methods. Similarly, for the ward level analyses, wardwide outcomes will be compared in wards before and after the implementation of the intervention: mean number of inpatient days, mean number of inpatient days with compulsory care, mean number of involuntary treatment interventions and overall ward burden. Distribution of the variables to be studied will determine whether parametric or non-parametric analyses are employed. Data analysis: Qualitative data Free text responses to the open-ended questions at the end of the quantitative interview (see patient level data above) as well as data from individual patient interviews and focus group interviews with staff and next-of-kin will be analyzed using content analysis and thematic analysis. Ethics All participants (patients, next-of kin and staff) are given written and oral information about the study, the voluntary participation, possibility to withdraw from participation without having to give explanation. All will sign consent form before participating in any study related task, a copy of signed consent is given participants. The study was approved by the Regional Ethics Board in Gothenburg, Dnr. 773-13. Time plan Data collection for the pre-intervention phase is completed (December 2014); the educational intervention is completed (May 2015) and the implementation period will end April 30, 2017. Focus group interviews with staff regarding the educational package are now underway (2017). Audit to determine the level of PCPC implementation is currently underway (April 2017), which will determine whether post-intervention data collection could start. Complete data set should be available fall 2017. Comment on project so far This is a complex intervention involving action research and the study is registered first after the completion of the educational intervention and on-ward implementation of PCPC. The implementation process has been dynamic and varied at the four different wards involved in the project. The duration of the implementation period was considerably longer than anticipated. This is in part related to high staff turnover, serious lack of psychiatrically trained RNs, as well as other barriers to implementation. Barriers have slowly been overcome by changes in routines instigated from within the care staff (as opposed to being imposed on staff from "above"). While the long implementation process can be seen as a limitation, it's interactive nature can at the same time be construed as a strength, as change from within can be expected to increase sustainable change. A quantitative study was planned with questionnaires investigating consumer satisfaction and care giver burden in next-of-kin but baseline collection resulted in too few participants to continue that subproject.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Non-randomized before and after design.
| Arm | Type | Receives |
|---|---|---|
| Pre-intervention | No intervention | –All patients at the psychosis wards receive care as usual before staff goes through educational intervention. |
| Post-intervention | Other | Behavioral: Person-centered psychosis careAfter staff attended educational intervention and implemented Person-centered psychosis care in the wards all patients admitted will receive person-centered care. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Diagnosis of psychotic illness in accordance with ICD-10
- Medically ready for discharge as deemed by ward psychiatrist
Key exclusion criteria (2 listed)
- Severe cognitive disability
- Lack of basic Swedish language skills
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Person-centered psychosis carePerson-centered care educational intervention for staff with following implementation of person-centered care in the clinic | Behavioural | Post-intervention |
Primary outcome
Change in patient empowerment (between before and after cohorts)
Time frame: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Patient reported empowerment measured by The Empowerment Scale (Rogers et al 2010).
4 secondary outcomes
Change in consumer satisfaction (between before and after cohorts)
Time frame: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Change in staff care burden (before and after intervention and implementation)
Time frame: Baseline, 2 years
Change in inpatient days with/out involuntary care (between before and after cohorts)
Time frame: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Change in involuntary treatment (between before and after cohorts)
Time frame: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Nov 2018.
- Background: PubMed 15925493Rossler W, Salize HJ, van Os J, Riecher-Rossler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005 Aug;15(4):399-409. doi: 10.1016/j.euroneuro.2005.04.009.
- Background: PubMed 19132962von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E, Jones P. Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl. 2009;(438):15-21. doi: 10.1111/j.1600-0447.2008.01309.x.
- Background: PubMed 19595447Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009 Aug 22;374(9690):620-7. doi: 10.1016/S0140-6736(09)60742-X.
- Background: PubMed 21850522Lasalvia A, Boggian I, Bonetto C, Saggioro V, Piccione G, Zanoni C, Cristofalo D, Lamonaca D. Multiple perspectives on mental health outcome: needs for care and service satisfaction assessed by staff, patients and family members. Soc Psychiatry Psychiatr Epidemiol. 2012 Jul;47(7):1035-45. doi: 10.1007/s00127-011-0418-0. Epub 2011 Aug 18.
- Background: PubMed 16968364Hamann J, Langer B, Winkler V, Busch R, Cohen R, Leucht S, Kissling W. Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand. 2006 Oct;114(4):265-73. doi: 10.1111/j.1600-0447.2006.00798.x.
- Background: PubMed 16330606Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Do patients with schizophrenia wish to be involved in decisions about their medical treatment? Am J Psychiatry. 2005 Dec;162(12):2382-4. doi: 10.1176/appi.ajp.162.12.2382.
- Background: PubMed 18418028Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77(4):219-26. doi: 10.1159/000126073. Epub 2008 Apr 16.
- Background: PubMed 12752017Malm U, Ivarsson B, Allebeck P, Falloon IR. Integrated care in schizophrenia: a 2-year randomized controlled study of two community-based treatment programs. Acta Psychiatr Scand. 2003 Jun;107(6):415-23. doi: 10.1034/j.1600-0447.2003.00085.x.
- Background: PubMed 24932858Malm UI, Ivarsson BA, Allebeck P. Durability of the efficacy of integrated care in schizophrenia: a five-year randomized controlled study. Psychiatr Serv. 2014 Aug 1;65(8):1054-7. doi: 10.1176/appi.ps.201300164.
- Background: PubMed 21926072Ekman I, Wolf A, Olsson LE, Taft C, Dudas K, Schaufelberger M, Swedberg K. Effects of person-centred care in patients with chronic heart failure: the PCC-HF study. Eur Heart J. 2012 May;33(9):1112-9. doi: 10.1093/eurheartj/ehr306. Epub 2011 Sep 15.
- Background: PubMed 17445014Olsson LE, Karlsson J, Ekman I. Effects of nursing interventions within an integrated care pathway for patients with hip fracture. J Adv Nurs. 2007 Apr;58(2):116-25. doi: 10.1111/j.1365-2648.2007.04209.x.
- Background: PubMed 24666667Chenoweth L, Forbes I, Fleming R, King MT, Stein-Parbury J, Luscombe G, Kenny P, Jeon YH, Haas M, Brodaty H. PerCEN: a cluster randomized controlled trial of person-centered residential care and environment for people with dementia. Int Psychogeriatr. 2014 Jul;26(7):1147-60. doi: 10.1017/S1041610214000398. Epub 2014 Mar 26.
- Individual participant dataSharing planned: No
Related trials for Patient-Centered Care
Active, not recruitingObservational study
Adverse Events During Physical Therapy in Neurocritical ICU Patients
Critical Illness, Brain Injury
Recruiting
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Kidney Cancer, Bladder Cancer
RecruitingPhase 3
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
Acute Ischemic Stroke
Active, not recruiting
Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills
Serious Games, Transition-age Youth
Recruiting
Testing the Impact of the MOHR Follow-up Support
Primary Care Patients, Primary Care Center
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Margda Waern, Professor principal investigator
Göteborg University & Sahlgrenska University Hospital
Anneli Goulding, Phd study director
Sahlgrenska University Hospital & Göteborg University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Person-centered psychosis care in people with Patient-Centered Care and Psychiatry, run by Göteborg University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in patient empowerment (between before and after cohorts) (time frame: Baseline (for before-intervention cohort), 2 years (for after-intervention cohort)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03182283, which also lists 28 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2018.